ACR246, a first in next-generation 5T4-ADC, as a potential choice of treating 5T4-positive solid tumors.

ACR246 - Adcoris

irinotecan - Generic mfg.

Focus V (anlotinib) - Advenchen, Sino Biopharm

Xi Jiao; Zhenwei Miao; Jing Gao; Yunsheng Huang; Feng Wang; Yaowu Li; Li Yang; Shanhui Weng; Lin Shen

Apr 23, 2025